First Time Loading...

IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 468.04 USD -5.02% Market Closed
Updated: May 2, 2024

Wall Street
Price Targets

IDXX Price Targets Summary
IDEXX Laboratories Inc

Wall Street analysts forecast IDXX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDXX is 616.71 USD with a low forecast of 464.6 USD and a high forecast of 708.75 USD.

Lowest
Price Target
464.6 USD
1% Downside
Average
Price Target
616.71 USD
32% Upside
Highest
Price Target
708.75 USD
51% Upside

IDXX Last Price Targets
IDEXX Laboratories Inc

The latest public price target was made on Feb 8, 2023 by Unknown Analyst from Barclays , who expects IDXX stock to rise by 26% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
Barclays
590 USD
Upside 26%
1 year ago
Feb 8, 2023
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $590
Benzinga
Unknown Analyst
J.P. Morgan
550 USD
Upside 18%
1 year ago
Feb 7, 2023
JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $550
Benzinga
Unknown Analyst
Atlantic Equities
600 USD
Upside 28%
1 year ago
Feb 7, 2023
Atlantic Equities Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600
Benzinga
Unknown Analyst
Citigroup
268 USD
Downside 43%
1 year ago
Feb 2, 2023
Citigroup Maintains Buy on IDEX, Lowers Price Target to $268
Benzinga
Unknown Analyst
Oppenheimer
247 USD
Downside 47%
1 year ago
Feb 2, 2023
Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $247
Benzinga
Unknown Analyst
Barclays
Price Target 590 USD
Upside/Downside 26%
View Source
Unknown Analyst
J.P. Morgan
Price Target 550 USD
Upside/Downside 18%
View Source
Unknown Analyst
Atlantic Equities
Price Target 600 USD
Upside/Downside 28%
View Source
Unknown Analyst
Citigroup
Price Target 268 USD
Upside/Downside 43%
View Source
Unknown Analyst
Oppenheimer
Price Target 247 USD
Upside/Downside 47%
View Source
IDEXX Laboratories Inc Competitors:
Price Targets
MYO
Myomo Inc
59% Upside
3600
Modern Dental Group Ltd
3% Upside
PDEX
Pro-Dex Inc
48% Upside
PRN
Profound Medical Corp
63% Upside
SRT
Sartorius AG
69% Upside
SENS
Senseonics Holdings Inc
260% Upside
TMDX
Transmedics Group Inc
14% Downside
GMED
Globus Medical Inc
24% Upside

Revenue
Forecast

Revenue Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 11%. The projected CAGR for the next 3 years is 10%.

11%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 17%. The projected CAGR for the next 3 years is 12%.

17%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 20%. The projected CAGR for the next 3 years is 14%.

20%
Past Growth
14%
Estimated Growth
Estimates Accuracy
5%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDXX's stock price target?
Price Target
616.71 USD

According to Wall Street analysts, the average 1-year price target for IDXX is 616.71 USD with a low forecast of 464.6 USD and a high forecast of 708.75 USD.

What is IDEXX Laboratories Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 11%. The projected CAGR for the next 3 years is 10%.

What is IDEXX Laboratories Inc's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 17%. The projected CAGR for the next 3 years is 12%.

What is IDEXX Laboratories Inc's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 20%. The projected CAGR for the next 3 years is 14%.